ProShares Ultra Nasdaq Biotechnology (BIB)
BIB is a passive ETF by ProShares tracking the investment results of the NASDAQ Biotechnology Index (200%). BIB launched on Apr 7, 2010 and has a 0.95% expense ratio.
Share Price Chart
Loading data...
Performance
The chart shows the growth of $10,000 invested in ProShares Ultra Nasdaq Biotechnology in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $69,051 for a total return of roughly 590.51%. All prices are adjusted for splits and dividends.
Compare to other instruments
Return
ProShares Ultra Nasdaq Biotechnology had a return of -10.29% year-to-date (YTD) and -14.49% in the last 12 months. Over the past 10 years, ProShares Ultra Nasdaq Biotechnology had an annualized return of 10.84%, outperforming the S&P 500 benchmark which had an annualized return of 9.86%.
| Period | Return | Benchmark |
|---|---|---|
| 1 month | -6.91% | -0.66% |
| Year-To-Date | -10.29% | 3.42% |
| 6 months | 9.54% | 5.67% |
| 1 year | -14.49% | -10.89% |
| 5 years (annualized) | -0.69% | 8.95% |
| 10 years (annualized) | 10.84% | 9.86% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | 6.78% | -13.34% | ||||||||||
| 2022 | -5.90% | 17.27% | 10.93% | -6.89% |
Dividend History
ProShares Ultra Nasdaq Biotechnology granted a 0.04% dividend yield in the last twelve months. The annual payout for that period amounted to $0.02 per share.
| Period | TTM | 2022 |
|---|---|---|
| Dividend | $0.02 | $0.02 |
Dividend yield | 0.04% | 0.03% |
Monthly Dividends
The table displays the monthly dividend distributions for ProShares Ultra Nasdaq Biotechnology. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | $0.00 | $0.00 | ||||||||||
| 2022 | $0.02 |
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below shows the maximum drawdowns of the ProShares Ultra Nasdaq Biotechnology. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.
The maximum drawdown since January 2010 for the ProShares Ultra Nasdaq Biotechnology is 67.24%, recorded on Jun 27, 2016. It took 1152 trading sessions for the portfolio to recover.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -67.24% | Jul 21, 2015 | 237 | Jun 27, 2016 | 1152 | Jan 25, 2021 | 1389 |
| -64.76% | Feb 9, 2021 | 339 | Jun 13, 2022 | — | — | — |
| -41.45% | May 13, 2011 | 60 | Aug 8, 2011 | 112 | Jan 18, 2012 | 172 |
| -39.01% | Feb 26, 2014 | 33 | Apr 11, 2014 | 114 | Sep 24, 2014 | 147 |
| -36.3% | Apr 16, 2010 | 48 | Jul 1, 2010 | 93 | Dec 17, 2010 | 141 |
| -24.73% | Oct 8, 2012 | 27 | Nov 15, 2012 | 71 | Mar 1, 2013 | 98 |
| -20.33% | May 15, 2013 | 26 | Jun 20, 2013 | 14 | Jul 11, 2013 | 40 |
| -17.74% | Mar 23, 2015 | 28 | Apr 30, 2015 | 34 | Jun 18, 2015 | 62 |
| -17.57% | Oct 2, 2013 | 6 | Oct 9, 2013 | 32 | Nov 22, 2013 | 38 |
| -16.83% | Sep 25, 2014 | 14 | Oct 14, 2014 | 7 | Oct 23, 2014 | 21 |
Volatility Chart
Current ProShares Ultra Nasdaq Biotechnology volatility is 40.07%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.